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Abstract
Background: Enabling women living with HIV to effectively plan whether and when to become pregnant is an
essential right; effective prevention of unintended pregnancies is also critical to reduce maternal morbidity and
mortality as well as vertical transmission of HIV. The objective of this study is to examine the use of family planning
(FP) services by HIV-positive and HIV-negative women in Kenya and their ability to achieve their fertility desires.
Methods: Data are derived from a random sample of women seeking family planning services in public health
facilities in Kenya who had declared their HIV status (1887 at baseline and 1224 at endline) and who participated in
a longitudinal study (the INTEGRA Initiative) that measured the benefits/costs of integrating HIV and sexual/
reproductive health services in public health facilities. The dependent variables were FP use in the last 12 months and
fertility desires (whether a woman wants more children or not). The key independent variable was HIV status (positive
and negative). Descriptive statistics and multivariate logistic regression analysis were used to describe the women’s
characteristics and to examine the relationship between FP use, fertility desires and HIV status.
Results: At baseline, 13 % of the women sampled were HIV-positive. A slightly higher proportion of HIV-positive
women were significantly associated with the use of FP in the last 12 months and dual use of FP compared to HIV-
negative women. Regardless of HIV status, short-acting contraceptives were the most commonly used FP methods. A
higher proportion of HIV-positive women were more likely to be associated with unintended (both mistimed and
unwanted) pregnancies and a desire not to have more children. After adjusting for confounding factors, the multivariate
results showed that HIV-positive women were significantly more likely to be associated with dual use of FP
(OR = 3.2; p < 0.05). Type of health facility, marital status and household wealth status were factors associated
with FP use. Factors associated with fertility desires were age, education level and household wealth status.
Conclusions: The findings highlight important gaps related to utilization of FP among WLHIV. Despite having
a greater likelihood of reported use of FP, HIV-positive women were more likely to have had an unintended pregnancy
compared to HIV-negative women. This calls for need to strengthen family planning services for WLHIV to ensure they
have better access to a wide range of FP methods. There is need to encourage the use of long-acting reversible
contraceptive (LARC) to reduce the risk of unintended pregnancy and prevention of vertical transmission of
HIV. However, such policies should be based on respect for women’s right to informed reproductive choice in
the context of HIV/AIDS.
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Background
According to the UNAIDS, at the end of 2010, an esti-
mated 34 million people were living with HIV and sub-
Saharan Africa continues to be disproportionately affected
by the epidemic. The region accounts for about 68 % of all
people living with HIV with women accounting for over
half (59 %) of all people living with HIV globally [1]. With
major efforts directed at expanding access to life-saving
antiretroviral therapy (ART) in sub-Saharan Africa [2],
many people on ART are leading productive and sexually
active lives and so face challenges in having pregnancies
only when intended. Unintended pregnancies (this in-
cludes both unwanted and mistimed) and the potential of
vertical transmission of HIV to the child are some of the
challenges faced by HIV-positive women. Unintended
pregnancies for all women can have negative health, eco-
nomic and social consequences for the woman and child,
including increased maternal morbidity and mortality,
poor breastfeeding and nutritional status and infant mor-
tality [3]. For HIV-positive women, the likelihood of ad-
verse health outcomes associated with pregnancy are
elevated due to a number of factors including faster de-
cline in CD4 count after pregnancy, HIV-related infections
and co-morbid conditions (for example, diabetes) [4–9].
Studies in Kenya and Malawi found that 54 and 40 % of
HIV-positive women, respectively, reported that their last
childbirth was unintended and modern contraceptive use
was lower among HIV-positive than HIV-negative women
(26 vs. 46 % in Kenya; 19 vs. 46 % in Malawi). Among
HIV-positive women who did not want a child ever or in
the next two years, less than a third in Kenya and less than
a fifth in Malawi were using a modern contraceptive [10].
Enabling women living with HIV to use contraception
effectively is a cost-effective strategy that can decrease the
number of unintended pregnancies and in turn reduce ma-
ternal mortality and vertical transmission of HIV [11–17].
However, this strategy is undervalued and not fully appreci-
ated by those responsible for implementing SRH and HIV
programs [18]. At the global level, prevention of unin-
tended pregnancies among women living with HIV has
been identified as one of the major components of a com-
prehensive strategy on prevention of mother-to-child
(PMTCT) HIV transmission [19].
Women living with HIV, like all women, have a right
to make and act freely and voluntarily upon their repro-
ductive decisions, including whether and when to be-
come pregnant. The ability to bear children continues to
have a high social value in Kenya and many women liv-
ing with HIV desire to become pregnant to avoid being
shunned or stigmatized or to sustain their marriage and
to leave children as their legacy should they die from
AIDS [20, 21]. Understanding the fertility preferences
and reproductive decisions of HIV-positive women is
vital for informing policy and programmatic efforts to
enable them to achieve these desires effectively and
safely). Evidence on fertility desires and family planning
among WLHIV has been growing [22–32]. This study
describes and compares use of family planning and fer-
tility desires among HIV-positive and HIV-negative
women attending 12 rural and peri-urban public health
facilities for FP services in five counties in the Central
region of Kenya.
Methods
Description of intervention
The Integra Initiative was a multi-country research study
measuring the feasibility, effects and costs of integrated
HIV and sexual and reproductive health services in Kenya
and Swaziland. The integrated HIV and FP service model
developed explicit linkages with FP services and relevant
HIV/AIDS services, and enabling linkage with antiretroviral
therapy (ART) services for eligible clients, either on-site or
through referral to other health facilities. Before recruit-
ment of participants, providers in study intervention facil-
ities were trained in provision of integrated services using a
Balanced Counselling Strategy Plus algorithm (BCS+) and a
standardised mentorship strategy described elsewhere [33].
Study implementation begun after intervention-facility pro-
viders were certified as attaining a pre-determined mini-
mum level of clinical skills. To be eligible for inclusion
in the FP-HIV study, the women had to be aged
15 years and over, be revisit FP clients, be living in
the catchment area of the health facility, and willing
to give their informed consent to be interviewed. The
study methodology used to evaluate the intervention
is described in detail elsewhere [34].
Study population and sampling
The data were collected through the INTEGRA Initiative -
a multi-country research study measuring the benefits and
costs of integrated HIV and sexual and reproductive health
services (www.integrainitiative.org). The study sample was
selected randomly from women seeking family planning
services at 12 public health facilities in Kenya. Participants
were recruited between November 2009 and May 2010 as
a cohort of women using FP that were followed for
24 months during which measures were made three times
to determine trends in several reproductive health indica-
tors, including fertility desires, pregnancy status (both
planned and unintended), consistency in use of FP, and
HIV status.
A total of 1959 women were recruited at baseline, of
which 1636 (83.5 %) were reported being HIV-negative
and 251 (12.8 %) reported being HIV-positive; 72 women
declined to report their HIV status. At endline, 1224
women remained in the cohort, of which 1068 (87.3 %)
were HIV-negative and 156 (12.7 %) were HIV-positive.
For this analysis, we used baseline and endline data only,
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and included only women willing to report their HIV
status. The desired sample size of 1959 was calculated to
test the larger study hypothesis that exposure to the FP
model of intervention would lead to an increase in con-
dom use in addition to another contraceptive method by
at least 5 percent among sexually active women over
two years and to allow for 30 % loss-to-follow up.
The women were recruited from 12 public health facil-
ities which were purposively selected based on provision
of a minimum range of services (FP, voluntary counsel-
ing and testing (VCT), STI treatment, and PMTCT) and
a minimum number of FP clients (100 or more per
month). The health facilities were located in peri-urban
and rural areas of five counties in Kenya; the facilities
comprised four hospitals and eight health centres. All
women seeking FP services from the health facilities on
the days when the research team was present were
approached for recruitment until the desired sample size
was reached. For inclusion, the women had to be aged
15 years and over, live in the catchment area of the
health facility, and give their informed consent to be
interviewed. All adolescents 15 – 17 years were only
interviewed following parental consent.
Data collection
A closed-ended questionnaire was used to collect data on
women’s fertility intentions, pregnancy, use of FP, other
SRH and STI/HIV-related behaviors and health-seeking
behaviors. Women were also asked whether they ever had
an HIV test, whether they knew their status, and if so,
whether they were willing to voluntarily disclose their
status. There was no pressure for them to disclose their
HIV status and unwillingness to do so was not a criterion
for exclusion from participating in the INTEGRA study.
Trained research assistants conducted the interviews
using hand-held personal digital assistants (PDAs) loaded
with the questionnaire tool translated into Swahili. Every
respondent was given a full description of the study and
gave their informed consent in writing prior to interview.
Data analysis
Descriptive, bivariate and multivariate analyses were car-
ried out using STATA ® version 10. The descriptive and
bivariate analyses were used to describe the characteris-
tics of the sample and explore the associations between
FP use in the last 12 months, fertility desires and the
woman’s HIV status. Chi-square (X2) and Fisher’s Exact
tests were used for bivariate analyses. Multivariate logis-
tic regression analysis was conducted to examine these
relationships controlling for potential confounding fac-
tors (including marital status, education, and household
socioeconomic status (SES) identified in previous re-
search [21, 30, 35–37]. The analysis models included an
interaction term between HIV status and timing of data
collection to assess changes in FP use and fertility de-
sires over time.
Table 1 summarizes the operational definitions for the
study variables.
Ethical considerations
The study was approved by the Kenya Medical Research
Institute (KEMRI) Ethical Review Board (IRB approval
Table 1 Definition of variables in the analysis
Variable Operational definition
Dependent variables
Used family planning method in last 12 months Yes = 1 and No = 0
Desires more children Yes = 1, No = 0 and Undecided = 2
Key independent variables
HIV status Positive = 1 and Negative = 0
Number of children desired Average number desired
Facility type Health center = 1 and Hospital = 0
Dual protection in the last 12 months
(condom use with another FP method)
Yes = 1 and No = 0
Timing of next birth 1 to 2 years = 1 and 3 years or more = 2
Intention regarding last birth Wanted to be pregnant = 1, Mistimed = 2, and Unwanted = 3
Other independent variables
Age of respondents 0 = 15-24 years, 1 = 25-34 years, 2 = 35+ years
Marital status 0 = Married, 1 = Single, and 2 = Divorced/separated/widowed
Education 0 = Primary and below, 1 = Secondary/higher
Household SESa 0 = Non-poor and 1 = Poor
aHousehold SES was computed using the principal component analysis technique and the items used for computation included ownership of different household
items such as television, radio, bicycle and use of different types of sources of fuel for cooking
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numbers 113 and 114), the Population Council’s Institu-
tional Review Board (IRB approval numbers 443 and 444),
and the Ethics Review Committee of the London School
of Hygiene & Tropical Medicine (LSHTM) (IRB approval
number 5426). The Integra Initiative is registered on the
Clinical Trials registration site: ClinicalTrials.gov Identi-
fier: NCT01694862. All research staff were trained and
certified in research ethics. Written informed consent was
obtained from all participants.
Results
Descriptive analysis
Table 2 summarizes the socio-demographic characteris-
tics of the study samples at baseline. HIV-positive
women were older, much less likely to be married, were
poorer and less educated. Most HIV-positive women
(94 %) and 66 % of HIV-negative women visited hospi-
tals to seek for care.
Table 3 presents the bivariate associations between
HIV status and explanatory variables at baseline and
endline. Overall, the sample size at endline is smaller
than at baseline and this could be attributed to loss-to-
follow up. For example, among HIV-positive women,
death from AIDS complications or migration could be
plausible explanations.
Fertility desires and HIV status
Significantly higher proportions of HIV-positive women
reported not wanting to have more children but there
were no significant differences in the number of children
desired (Table 3). Further analysis showed that more HIV-
positive women than HIV-negative women already had
their desired number of children (60 vs. 39 %; p < 0.001).
At baseline, HIV-positive women were more likely to re-
port wanting to become pregnant within one to two years
(52 vs. 20 %; p < 0.001) than HIV-negative women, but at
endline there was no statistically significant difference.
At baseline, a significantly higher proportion of HIV-
positive women reported that their last birth was unin-
tended (either mistimed or unwanted). At endline, only
12 HIV-positive women had a pregnancy since recruit-
ment and out of these, eight said their pregnancy was
unintended.
Family planning use and HIV status
At baseline, slightly more HIV-positive women than
HIV-negative women used family planning in the last
12 months (p < 0.001). At endline, the proportion of
those who used family planning decreased in both
groups but the margin was higher among HIV-positive
women (p = 0.772)(Table 3). Short-term FP methods
were the mostly commonly used methods in the last
12 months (Table 4). In both study rounds, fewer HIV-
positive than HIV-negative women used hormonal pills
and injectables; however, there was an increase in the
proportion of HIV-positive women who used the two FP
methods. More HIV-positive than HIV-negative women
used male condoms at baseline (41 vs. 1 %; p < 0.001)
and endline (26 vs. 2 %; p < 0.001). Women who were re-
cruited at health centers (regardless of HIV status) were
more likely to use hormonal pills than women recruited
at hospitals (37 vs. 26 %; p < 0.001). There were no sig-
nificant differences by facility type among women who
used injectables (53 vs. 51 %; p = 0.254). More women
who were recruited at hospitals (regardless of HIV sta-
tus) reported using implants and IUCDs than women
recruited at health centers (6 vs. 2 %; p < 0.001) and
(8 vs. 5 %; p = 0.006), respectively.
Further analysis showed that among women with un-
intended pregnancy (regardless of HIV status), a majority
reported using injectables (52 %), 25 % used hormonal
pills, 8 % used IUCDs and 6 % used implants.
Dual protection and HIV status
Dual protection (use of condom and another FP method)
was significantly higher among HIV-positive than HIV-
negative women at baseline (41 vs. 3 %; p < 0.001) and
endline (87 vs. 8 %; p < 0.001), and increased dramatically
over the two-year period; among HIV-negative women
there was also a significant increase in the proportion
reporting dual protection (Table 3).
Table 2 Socio-demographic characteristics by HIV status at
baseline
HIV-positive
(N = 251)
HIV-negative
(N = 1,636)
p value
% %
Age of respondents
15–24 years 4 32 <0.001
25–34 years 51 51
35+ years 45 17
Mean age in years (SD) 34 (6.1) 28 (6.0) <0.001
Marital status
Single 22 3 <0.001
Married 62 96
Divorced/separated/
widowed
16 1
Education
Primary and below 71 58 <0.001
Secondary and
higher
29 42
Household SES
Poor 56 47 0.020
Non-poor 44 53
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Multivariate analysis
Family planning use and HIV status
Table 5 presents results from the multivariate regression
analysis. At baseline, HIV-positive women were 8.5 times
more likely to have used FP during the previous 12 months
than HIV-negative women. Contraceptive use during the
previous 12 months declined among both groups at end-
line, but the decline was higher among HIV-positive
women.
Women who were recruited at health centers were sig-
nificantly more likely to have used FP in the previous
12 months than women recruited at hospitals. Unmarried
Table 3 Bivariate associations between HIV status and explanatory variables
Baseline Endline
HIV-positive HIV-negative HIV-positive HIV-negative
% (N) % (N) p-values % (N) % (N) p-values
Desire more children
No 80 (201) 44 (727) 82 (66) 57 (300) ***
Yes 18 (46) 52 (843) *** 15 (12) 42 (218)
Undecided 2 (4) 4 (65) 3 (2) 1 (6)
Average number of children desired (standard deviation) 3.0 (1.4) 3.1 (1.0) 0.323 3.2 (1.1) 3.3 (1.0) 0.278
Timing of next birth
1–2 years 52 (24) 20 (169) 36 (5) 29 (64) 0.568
3 years or more 48 (22) 80 (674) *** 64 (9) 71 (160)
Intention regarding last birth
Wanted to be pregnant then 57 (142) 70 (1,144) 33 (4) 71 (72) **
Mistimed (wanted to be pregnant later) 28 (70) 21 (347) *** 25 (3) 24 (24)
Unwanted (wanted no more children) 15 (38) 9 (142) 42 (5) 5 (5)
Used family planning in last 12 months 0.772
No 1 (3) 7 (121) *** 10 (16) 10 (102)
Yes 99 (247) 93 (1,505) 90 (140) 91 (966)
Dual protection in last 12 months
No 59 (146) 97 (1,461) *** 13 (14) 92 (879) ***
Yes 41 (101) 3 (44) 87 (90) 8 (72)
Facility type
Hospital 94 (237) 67 (1,105) 96 (150) 67 (721) ***
Health center 6 (14) 33 (531) *** 4 (6) 33 (347)
Age of respondents
15–24 years 4 (11) 32 (526) *** 1 (1) 15 (161) ***
25–34 years 51 (128) 51 (838) 44 (69) 56 (598)
35+ years 45 (112) 17 (272) 55 (86) 29 (309)
Marital status
Single 22 (56) 3 (45) 21 (33) 4 (38) ***
Married 62 (155) 96 (1,572) *** 57 (89) 93 (994)
Divorced/separated/widowed 16 (40) 1 (19) 22 (34) 3 (36)
Education
Primary and below 71 (178) 58 (955) ** 71 (108) 58(612) **
Secondary and higher 29 (73) 42 (681) 29 (43) 42 (434)
Household SES
Poor 56 (140) 47 (771) 0.011 56 (88) 51 (546) 0.217
Non-poor 44 (111) 53 (865) 44 (68) 49 (522)
*p < 0.05; **p < 0.01; ***p < 0.001; X2 and Fisher’s Exact test were used to test the association between HIV status and explanatory variables
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and non-poor women, regardless of HIV status, were less
likely to have used FP in the previous 12 months; educa-
tion did not influence FP use.
Dual protection and HIV status
As indicated in Table 6, HIV-positive women were 17
times more likely to use dual protection than HIV-
negative women and this increased substantially over
time. The only other influential factor was marital status,
with unmarried women more than two and a half times
more likely to practice dual protection than married
women.
Fertility desires and HIV status
Table 7 shows that HIV-positive women were 2.5 times
more likely not to want more children than HIV-
negative women. Regardless of HIV status, older, poorer,
less educated women were more likely to want no more
children; marital status was not influential.
Discussion
The objective of this paper was to examine family plan-
ning use and fertility desires among women living with
HIV who attended FP clinics in resource-limited settings
in Kenya. The findings show that a high proportion of
Table 4 Type of FP methods used in the last 12 months by HIV status
Baseline Endline
HIV-positive (N = 247) HIV-negative (N = 1,505) p value HIV-positive (N = 140) HIV-negative (N = 966) p value
% (n) % (n) % (n) % (n)
Hormonal pills 13 (32) 32 (485) <0.001 14 (19) 30 (294) <0.001
Injectables 36 (90) 59 (880) <0.001 41 (57) 45 (433) 0.360
Male condoms 41 (101) 1 (18) <0.001 26 (36) 2 (15) <0.001
IUCD 3 (8) 4 (55) 0.745 6 (9) 15 (140) 0.009
Implants 2 (6) 3 (51) 0.431 11 (15) 7 (67) 0.111
Female sterilization 2 (6) 0 (0) <0.001 3 (4) 1 (8) 0.030
Table 5 Adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) for family planning use and explanatory variables
Variables Family planning use
Without interaction term (HIV status and
study round)
With interaction term (HIV status and
study round)
Adjusted OR 95 % CI Adjusted OR 95 % CI
HIV status (Ref = HIV-negative)
HIV-positive 3.4** [1.7–6.8] 8.5** [2.4–30.5]
Study round (Ref = Baseline)
Endline 0.7* [0.5–1.0] 0.8 [0.6-1.2]
Facility type (Ref = Hospital)
Health center 1.5* [1.0–2.2] 1.5* [1.0-2.1]
Desire more children (Ref = Yes/undecided)
No 0.9 [0.6–1.4] 0.9 [0.6–1.4]
Number of children desired 0.9 [0.8–1.1] 0.9 [0.8–1.1]
Age of respondents (Ref = 15-24 years)
25-34 years 1.0 [0.7–1.5] 1.0 [0.7–1.4]
35+ years 1.3 [0.7–2.3] 1.3 [0.7–2.3]
Marital status (Ref = Married)
Not married 0.5* [0.3–0.9] 0.5* [0.3–0.9]
Education (Ref = Primary and below)
Secondary and higher 0.8 [0.6–1.1] 0.8 [0.6–1.2]
Household SES (Ref = Non-poor)
Poor 1.5* [1.1–2.2] 1.5* [1.1–2.2]
*p < 0.05; **p < 0.01; ***p < 0.001; Ref = reference category
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Table 6 Adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) for dual use of family planning and explanatory variables
Variables Dual use of family planning
Without interaction term (HIV status and
study round)
With interaction term (HIV status and
study round)
Adjusted OR 95 % CI Adjusted OR 95 % CI
HIV status (Ref = HIV-negative)
HIV-positive 22.8*** [13.8–37.8] 17.0*** [9.9–29.3]
Study round (Ref = Baseline)
Endline 3.3*** [2.3–4.8] 2.2** [1.4-3.6]
Facility type (Ref = Hospital)
Health center 0.8 [0.5–1.2] 0.8 [0.5-1.2]
Desire more children (Ref = Yes/undecided)
No 1.1 [0.8–1.7] 1.2 [0.8–1.8]
Number of children desired 1.0 [0.8–1.1] 1.0 [0.8–1.2]
Age of respondents (Ref = 15-24 years)
25-34 years 1.2 [0.7–1.9] 1.2 [0.7-2.0]
35+ years 0.6 [0.3–1.2] 0.7 [0.3–1.3]
Marital status (Ref = Married)
Not married 2.4** [1.4–4.1] 2.6** [1.5–4.4]
Education (Ref = Primary and below)
Secondary and higher 1.1 [0.7–1.6] 1.1 [0.7–1.6]
Household SES (Ref = Non-poor)
Poor 1.0 [0.7–1.5] 1.0 [0.7–1.5]
*p < 0.05; **p < 0.01; ***p < 0.001; Ref = reference category
Table 7 Adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) for fertility desires (wanting no more children) and
explanatory variables
Variables Fertility desires (wanting no more children)
Without interaction term (HIV status and study round) With interaction term (HIV status and study round)
Adjusted OR 95 % CI Adjusted OR 95 % CI
HIV status (Ref = HIV-negative)
HIV-positive 2.3*** [1.6–3.4] 2.5*** [1.6–3.7]
Study round (Ref = Baseline)
Endline 1.0 [0.8–1.2] 1.0 [0.8-1.2]
Facility type (Ref = Hospital)
Health center 1.0 [0.8–1.3] 1.0 [0.8-1.3]
Age of respondents (Ref = 15–24 years)
25–34 years 3.9*** [3.1–5.0] 3.9*** [3.1–5.0]
35+ years 20.6*** [14.7–28.8] 20.6*** [14.7–28.7]
Marital status (Ref = Married)
Not married 1.3 [0.9–2.1] 1.4 [0.9–2.1]
Education (Ref = Primary and below)
Secondary and higher 0.7*** [0.6–0.8] 0.7*** [0.6–0.8]
Household SES (Ref = Non-poor)
Poor 1.5*** [1.2–1.9] 1.5*** [1.2–1.9]
*p < 0.05; **p < 0.01; ***p < 0.001; Ref = reference category
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women in the sample were HIV-positive (13 %), which is
much higher than the national rate of 5.6 % [38] .
Family planning use and HIV status
We also found that a majority of women in the sample
had used FP in the last 12 months and short-term contra-
ceptives were the mostly commonly used methods. There
were significant differences in FP use by HIV status. Simi-
lar to previous studies [30, 39], our study showed that
HIV-positive women were more likely to use FP compared
to HIV-negative women. However, over time, there was a
general reduction in FP use and the decline was greater
among HIV-positive than HIV-negative women. We could
not find a plausible explanation for this finding. Similar to
previous research [40], we found that most HIV-positive
women used condoms compared to HIV-negative women.
This finding suggests the FP advice received from pro-
viders is dominated by ‘condom’ messages. Further ana-
lysis, showed there was a slight increase in the average
number of children desired among HIV-positive women
at endline, which is consistent with the decline in FP use
at endline. A previous study in Kenya and Zambia found
no differences in the use of contraceptives between HIV-
positive and HIV-negative women except in condom use
[20]. Type of health facility was significantly associated
with family planning use. Women who visited a health
center had a higher likelihood of using family planning
compared to women who went to a hospital. One plaus-
ible reason for this finding is that women only needed
short-acting contraceptives and not long-acting contra-
ceptives, which require a higher level of clinical skills and
equipment than shorter-term methods and these, are
more likely to be found in a higher-level facility.
Consistent with previous research conducted in Kenya
to assess the attitudes toward family planning among
HIV-positive pregnant women [35], our study findings
showed that marital status was also an important deter-
minant of family planning use. Women who were not
married were less likely to use family planning compared
to married women. Household socioeconomic status was
associated with family planning use. Women from poor
households were more likely to use family planning com-
pared to their counterparts from wealthier households.
This observation is further supported by the results from
the multivariate regression model on fertility desires,
which showed that women from poor households were
more likely not to desire more children compared to
women from wealthier households. One plausible explan-
ation is that providers could be promoting more FP use to
poorer households or (perhaps more likely) the motivation
to use contraceptives is higher because of poverty or ex-
pense of bringing up children (poorer households feel the
burden more). These findings are not consistent with pre-
vious research in Zambia and Swaziland which found that
women from wealthier households were more likely to be
associated with contraceptive use compared to women
from poorer households [30].
Dual protection and HIV status
A higher proportion of HIV-positive women were associ-
ated with dual method use compared to HIV-negative
women. Previous Integra research also confirmed that dual
method use was higher among HIV-positive than HIV-
negative women in Swaziland [40]. Women who were not
married were more likely to be associated with dual use of
family planning compared to married women. This sug-
gests that women who are not married are using condoms
(most likely during casual sexual encounters) in addition to
another family planning method unlike their married coun-
terparts for whom condom use is low [38, 41, 42], and is
mostly associated with disease and infidelity.
Fertility desires and HIV status
The proportion of mistimed and unintended pregnan-
cies was higher among HIV-positive women compared
to HIV-negative women. This finding is similar to pre-
vious research, which found high numbers of mistimed
pregnancies among Women living with HIV [39].
Among women with unintended pregnancy (regardless
of HIV status), a majority reported using short-term
family planning methods. This finding corroborates
previous research conducted in Swaziland which found
only short-acting methods were used prior to the most
recent pregnancy [40]. This finding suggests that chal-
lenges still exist with regard to helping women avoid
unintended pregnancies; further mixed-methods re-
search with HIV-positive women reported elsewhere,
suggests this may be because of lack of access to more
effective (less user/partner dependent) long-acting
contraception [43].
Similar to previous research [10, 21, 22, 29, 30, 43], our
study findings show that at baseline, HIV-positive women
were less likely to want more children compared to HIV-
negative women. However, over time, there were no signifi-
cant differences in fertility desires between the two groups.
Age was a significant predictor of fertility desires. Generally,
the likelihood of not wanting more children increased with
age. This finding is consistent with previous studies which
found that older women were less likely to want more chil-
dren compared to younger women [21, 30]. Education level
and household socioeconomic status were associated with
fertility desires. Women with secondary and higher educa-
tion were more likely to want more children compared to
their counterparts with primary education and lower. Find-
ings from previous studies on the association between edu-
cation and fertility desires were mixed. In Zambia, women
with no education and those with higher education
were associated with a higher likelihood of wanting
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more children compared to those with secondary educa-
tion. While in Lesotho, women with higher level educa-
tion did not want to have more children (Johnson et al.,
2009) compared to those with secondary education. How-
ever, a meta-analysis of fertility desires of people living
with HIV found no strong association of fertility desire
with better education (Berhan Y and Berhan A, 2013).
The findings from our study have important implications
for policy and programmatic efforts aimed at addressing
sexual and reproductive health and HIV needs of women.
First, the proportion of women who are infected with HIV
is higher than the national rate highlighting the need to
ramp up efforts aimed at addressing the increased risk of
acquiring HIV among women. Prevention of unintended
pregnancies (i.e., for prevention of mother-to-child HIV
transmission) and promotion of dual protection are import-
ant measures here. Second, our study results suggest that
despite the high uptake family planning methods among
HIV-positive women, the proportion of mistimed and unin-
tended pregnancies was higher among HIV-positive women
compared to HIV-negative women. This calls for need to
strengthen family planning services for HIV-positive
women by addressing the underlying factors that may place
these women at increased risk of unintended pregnancies.
At the global level, prevention of unintended pregnancies
among HIV-positive women has been identified as one of
the major components of a comprehensive strategy on pre-
vention of mother-to-child (PMTCT) HIV transmission
[19]. Our study found that short-acting contraceptives were
the most commonly used methods. There is need to en-
courage the use of long-acting reversible contraceptive
(LARC) to reduce the risk of unintended pregnancy. These
methods do not require maintenance and last for a longer
period compared to short-acting contraceptives.
The lost-to-follow-up (LFU) was 30 and 28 % for the
intervention and comparison groups, respectively. The
LFU was within the anticipated range (30 %) and a sensi-
tivity check suggested that it was random not systematic,
and, therefore, no effect on the findings.
Limitations
Our study had a number of limitations that need to be
highlighted. First, the data on HIV status was self-
reported and, therefore, may have been subject to bias
(either under reporting or over reporting, though the
latter is unlikely) since individuals have a propensity to
provide socially desirable responses, especially to ques-
tions on sensitive subject matter. Second, due to lack of
data on cultural beliefs and practices, we were unable to
assess the association between these factors and fertility
desires among women living with HIV. Evidence shows
that cultural factors play an important role in shaping
decisions related to childbearing [21, 22]. Other Integra
publications use qualitative data to explore cultural and
stigma-related factors related to fertility and contraceptive
use (Mayhew SH, Colombini M, Tomlin K, Kimani J,
Warren C, ZhouW, Mutemwa R, for the Integra Initiative.
I do not like getting a baby when I have not planned…”
Fertility intentions, contraceptive practices and inappropri-
ately met need, among women living with HIV in Kenya.
(Submitted)), [44]. Also, since the data for this study was
collected from women seeking family planning services
from selected public health facilities in one of the eight
administrative regions in Kenya, we cannot generalize
about family planning use and fertility desires among all
women in Kenya. However, our findings provide important
insights about use of FP vis-à-vis unintended pregnancies
among women living with HIV in resource-limited settings.
Conclusion
In conclusion, our study findings highlight the need and
importance of making family planning services an inte-
gral and continuous part of HIV prevention, treatment
and care programming initiatives. HIV-positive women
who desire to limit childbearing should be identified and
supported to address factors exposing them to increased
risk of unintended pregnancies.
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